Literature DB >> 10523013

Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels.

A M Isidori1, M Caprio, F Strollo, C Moretti, G Frajese, A Isidori, A Fabbri.   

Abstract

Leptin circulates in plasma at concentrations that parallel the amount of fat reserves. In obese males, androgen levels decline in proportion to the degree of obesity. Recently, we have shown that in rodent Leydig cells leptin inhibits hCG-stimulated testosterone (T) production via a functional leptin receptor isoform; others have found that leptin inhibits basal and hCG-induced T secretion by testis from adult rats. In this study, we further investigated the relationship linking leptin and androgens in men. Basal and hCG-stimulated leptin and sex hormone levels were studied in a large group of men ranging from normal weight to very obese (body mass index, 21.8-55.7). Initial cross-sectional studies showed that circulating leptin and fat mass (FM) were inversely related with total and free T (r = -0.51 and r = -0.38, P < 0.01 and P < 0.05, respectively). Multiple regression analysis indicated that the correlation between leptin or FM and T was not lost after controlling for SHBG and/or LH and/or estradiol (E2) levels and that leptin was the best hormonal predictor of the lower androgen levels in obesity. Dynamic studies showed that in obese men the area under the curve of T and free T to LH/hCG stimulation (5000 IU i.m.) was 30-40% lower than in controls and inversely correlated with leptin levels (r = -0.45 and r = -0.40, P < 0.01 and P < 0.05, respectively). Also, LH/hCG-stimulation caused higher increases in 17-OH-progesterone to T ratio in obese men than in controls, whereas no differences were observed between groups either in stimulated E2 levels or in the E2/T ratio. In all subjects, the percentage increases from baseline in the 17-OH-progesterone to T ratio were directly correlated with leptin levels or FM (r = 0.40 and r = 0.45, P < 0.01), but not with E2 or other hormonal variables. In conclusion, our studies, together with previous in vitro findings, indicate that excess of circulating leptin may be an important contributor to the development of reduced androgens in male obesity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523013     DOI: 10.1210/jcem.84.10.6082

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  109 in total

Review 1.  Obesity: modern man's fertility nemesis.

Authors:  Stephanie Cabler; Ashok Agarwal; Margot Flint; Stefan S du Plessis
Journal:  Asian J Androl       Date:  2010-06-07       Impact factor: 3.285

Review 2.  Metabolic syndrome, androgens, and hypertension.

Authors:  Mohadetheh Moulana; Roberta Lima; Jane F Reckelhoff
Journal:  Curr Hypertens Rep       Date:  2011-04       Impact factor: 5.369

Review 3.  Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies.

Authors:  Prasenjit Manna; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2015-12       Impact factor: 1.894

4.  Effects of Bariatric Surgery in Male Obesity-Associated Hypogonadism.

Authors:  Fernanda Augustini Rigon; Marcelo Fernando Ronsoni; Alexandre Hohl; Simone van de Sande-Lee
Journal:  Obes Surg       Date:  2019-07       Impact factor: 4.129

5.  Occurrence of erectile dysfunction, testosterone deficiency syndrome and metabolic syndrome in patients with abdominal obesity. Where is a sufficient level of testosterone?

Authors:  Juraj Fillo; Jan Breza; Michaela Levčíkova; Jan Luha; Anna Vachulova; Štefan Durdík; Peter Labaš
Journal:  Int Urol Nephrol       Date:  2012-08       Impact factor: 2.370

6.  [Clinical symptoms of hypogonadism after radical prostatectomy].

Authors:  D Ridderskamp; M Zellner
Journal:  Urologe A       Date:  2011-04       Impact factor: 0.639

7.  Insulin directly regulates steroidogenesis via induction of the orphan nuclear receptor DAX-1 in testicular Leydig cells.

Authors:  Seung Won Ahn; Gil-Tae Gang; Yong Deuk Kim; Ryun-Sup Ahn; Robert A Harris; Chul-Ho Lee; Hueng-Sik Choi
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

Review 8.  Epidemiology, diagnosis, and treatment of male hypogonadotropic hypogonadism.

Authors:  A Lenzi; G Balercia; A Bellastella; A Colao; A Fabbri; C Foresta; M Galdiero; L Gandini; C Krausz; G Lombardi; F Lombardo; M Maggi; A Radicioni; R Selice; A A Sinisi; G Forti
Journal:  J Endocrinol Invest       Date:  2009-12-01       Impact factor: 4.256

9.  Long-term follow-up of gonadal dysfunction in morbidly obese adolescent boys after bariatric surgery.

Authors:  Vivian L Chin; Kristen M Willliams; Tegan Donnelley; Marisa Censani; Rushika Conroy; Shulamit Lerner; Sharon E Oberfield; Donald J McMahon; Jeffrey Zitsman; Ilene Fennoy
Journal:  J Pediatr Endocrinol Metab       Date:  2018-11-27       Impact factor: 1.634

10.  Hypogonadotropic hypogonadism in a patient with morbid obesity.

Authors:  Miguel Angel Mollar Puchades; Rosa Cámara Gómez; Maria Isabel del Olmo García; José Luis Ponce Marco; Raquel Segovia Portolés; Pablo Abellán Galiana; Francisco Piñón Sellés
Journal:  Obes Surg       Date:  2007-08       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.